Figure 3From: Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? Incremental costs of using RDTs per malaria positive patient treated (base case): based on total costs of RDT and antimalarials (artesunate plus sulfadoxine-pyrimethamine and artemether-lumefantrine) when all suspected malaria cases are tested. Back to article page